![Scott T. Shearer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Shannon | M | 68 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 1 years |
Paul Sekhri | M | 66 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 5 years |
David Hoffmann | M | 79 | 26 years | |
Bruce Cozadd | M | 60 | 11 years | |
Peter Staple | M | 72 | 8 years | |
Gary Patou | M | 65 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 1 years |
Ernest Mario | M | 85 | 8 years | |
George Davy | M | 72 | 3 years | |
Michael DesJardin | M | 66 | 9 years | |
Kamran Hosseini | M | 59 | 2 years | |
Erik D. Wiberg | M | - | 8 years | |
Christopher Kurtz | M | 57 | - | |
Nacer E. Dean Abrouk | M | - | - | |
David Banks | M | - | 6 years | |
Joel A. Fernandes | M | 54 | 3 years | |
Carter J. King | M | 52 | 4 years | |
Matthew J. Meyer | M | 54 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 2 years |
Joanne Quan | M | 60 | 3 years | |
Nandan Oza | M | 61 | 15 years | |
Mark A. Evashenk | M | - | 1 years | |
Ronald P. Haak | M | - | 14 years | |
George Tyson | M | - | 9 years | |
Tetsuto Nagata | M | - |
Teikoku Pharma USA, Inc.
![]() Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | - |
Kimberley Gaumer | F | - | 22 years | |
Aron M. Knickerbocker | M | 54 | 1 years | |
David Abraham | M | 58 | 2 years | |
Carole Roth | F | - | 7 years | |
Jeff Hargroves | M | 58 | 3 years | |
Suneel Gupta | M | 66 | 12 years | |
Kevin Brodbeck | M | - | 6 years | |
Lawrence G. Hamel | M | 72 | 30 years | |
Michael W. Ramsay | M | 67 | 2 years | |
Padmanabh P. Bhatt | M | 66 | 5 years | |
Daniel J. Levitt | M | 76 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 2 years |
Michael Miller | M | 67 | 4 years | |
Detlef F. Albrecht | M | 63 | 10 years | |
Steven Ketchum | M | 59 | 8 years | |
Howard Rosen | M | 66 | 10 years | |
Steve Cartt | M | 61 | 15 years | |
Susan P. Rinne | F | 72 | 11 years | |
Ahmed Hamdy | M | 59 | 2 years | |
Joan E. Colligan | F | - | 4 years | |
Samuel Saks | M | 69 | 2 years | |
James W. Young | M | 79 | 5 years | |
Robert M. Myers | M | 60 | 9 years | |
Kin Hung Yu | M | 61 | 2 years | |
Natalie L. McClure | M | 71 |
Cerimon Pharmaceuticals, Inc.
![]() Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA. | 3 years |
Felix Theeuwes | M | 86 | 29 years | |
Daniel Swisher | M | 61 | 9 years | |
Matthew Fust | M | 59 | 6 years | |
Carol A. Gamble | F | 71 | 12 years | |
Ed F. Schnipper | M | 75 | 4 years | |
Janne L. T. Wissel | F | 68 | 22 years | |
Valerie Pierce | F | 61 | 5 years | |
Peter K. Working | M | 75 | 2 years | |
Asha Ramdas | F | - | - | |
Christopher Dammann | M | 54 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 57 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott T. Shearer
- Personal Network